A 28-year-old woman is undergoing emergency cesarean section under general anesthesia for placental abruption. After induction with thiopental and succinylcholine for intubation, anesthesia is maintained with nitrous oxide, oxygen, and isoflurane. At 20 minutes into surgery, the anesthesiologist notices a steady rise in end-tidal CO₂ (from 38 to 52 mmHg), core temperature 38.2°C, and muscle rigidity on palpation. The patient's jaw is clenched, and the surgical team reports difficulty with muscle relaxation despite recent administration of vecuronium. Arterial blood gas shows pH 7.28, PaCO₂ 58 mmHg, HCO₃⁻ 24 mEq/L, K⁺ 6.2 mEq/L. What is the primary pathophysiologic mechanism underlying these findings?

Explanation

## Pathophysiology of Malignant Hyperthermia ### The Molecular Basis of MH **Key Point:** Malignant hyperthermia is caused by mutations in genes encoding calcium-handling proteins of the sarcoplasmic reticulum (SR), most commonly the ryanodine receptor (RYR1) or the L-type calcium channel (CACNA1S). These mutations result in abnormal calcium release in response to triggering agents. ### Normal vs. MH Muscle Calcium Handling | Feature | Normal Muscle | MH-Susceptible Muscle | |---------|---------------|----------------------| | **Trigger exposure** | Succinylcholine/volatile agents | Succinylcholine/volatile agents | | **SR calcium release** | Tightly regulated, brief | Uncontrolled, sustained | | **Muscle contraction** | Coordinated, brief | Sustained, rigid | | **ATP consumption** | Normal | Massively increased (hypermetabolism) | | **Heat production** | Baseline | Exponential rise | | **CO₂ production** | Normal | Rapid rise (↑ETCO₂) | | **Myoglobin release** | Minimal | Massive (rhabdomyolysis) | ### The MH Cascade ```mermaid flowchart TD A[Succinylcholine or Volatile Anesthetic]:::outcome --> B[Abnormal RYR1/CACNA1S activation]:::outcome B --> C[Uncontrolled SR Ca²⁺ release]:::urgent C --> D[Sustained muscle contraction]:::urgent D --> E[Massive ATP consumption]:::urgent E --> F[↑ Aerobic + Anaerobic metabolism]:::urgent F --> G[↑ Heat production<br/>↑ CO₂ production<br/>↑ Lactate]:::urgent G --> H[Hyperthermia<br/>Respiratory acidosis<br/>Metabolic acidosis]:::outcome C --> I[Muscle membrane disruption]:::urgent I --> J[K⁺ + myoglobin release]:::urgent J --> K[Hyperkalemia<br/>Rhabdomyolysis<br/>Myoglobinuria]:::outcome K --> L[Cardiac arrhythmias<br/>Acute kidney injury]:::urgent ``` ### Clinical Evidence in This Case **High-Yield:** The triad of early MH signs: 1. **↑ETCO₂** (most sensitive early sign) — reflects hypermetabolism from uncontrolled muscle calcium cycling 2. **Hyperthermia** — late sign, but present here; indicates prolonged hypermetabolism 3. **Muscle rigidity** — sustained contraction from continuous calcium-mediated actin-myosin cycling **Clinical Pearl:** The laboratory findings confirm the mechanism: - **Respiratory acidosis** (pH 7.28, PaCO₂ 58) — from ↑CO₂ production exceeding ventilatory clearance - **Hyperkalemia** (K⁺ 6.2) — from sustained muscle contraction and rhabdomyolysis-induced potassium efflux - **Metabolic acidosis** (implied by low pH despite elevated HCO₃⁻) — from anaerobic metabolism and lactate accumulation ### Why Calcium Dysregulation Is Central In MH-susceptible individuals, the mutated calcium-handling proteins fail to properly terminate calcium release from the SR. This leads to: - Continuous actin-myosin cross-bridging (muscle rigidity) - Sustained ATP hydrolysis (energy crisis) - Heat generation from ATP hydrolysis and friction of sustained contraction - Muscle membrane breakdown (rhabdomyolysis) from mechanical stress and calcium overload **Warning:** ~~Inadequate anesthesia~~ would cause sympathetic hyperactivity and tachycardia, but NOT the characteristic ↑ETCO₂ or muscle rigidity despite adequate neuromuscular blockade. ~~Anaphylaxis~~ would present with bronchospasm, hypotension, and urticaria—not isolated muscle rigidity and hypermetabolism.